INDUSTRY Awards
Winner of Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
Winner of Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence 2025
This award recognizes Avance Clinical’s strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials.
Winner of Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence 2024
Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence.
Winner of South Australian Premier’s Business and Export Awards – 2023
Avance Clinical has won the category for International Health that recognizes the company’s outstanding international success in biotechnology and healthcare industry.
Winner of Frost & Sullivan 2023 Best Practices Customer Value Leadership Award
For the fourth consecutive year, Avance Clinical has been awarded Best Practices Customer Value Leadership awarded, by Frost and Sullivan, for its exceptional performance.
Finalist for 2023 Citeline Pharma Intelligence Awards in Japan – Executive of the Year
Chief Executive Officer Yvonne Lungershausen has been nominated for Executive of the Year in the 2023 Citeline Pharma Intelligence Awards in Japan.
Finalist for The Scrip Awards 2023 – Business Development Team of the Year
Scrip’s Business Development Team of the Year Award honors the achievements of business development teams whether they are from a pharma or biotech company or a cross-company team responsible for a specific deal or collaborative project.
Finalist for The Scrip Awards 2023 – Best Contract Research Organization
The Awards for the Best Contract Research Organization acknowledge the critical role that CROs play in drug development. As a specialist early stage CRO, Avance has been delivering clinical drug development services for international biotechs for over two decades.
Frost & Sullivan Practices Award - 2022
Frost & Sullivan has recognized Avance Clinical, the leading Australian-based biotech CRO with US operations, with the Frost & Sullivan’s 2022 Asia-Pacific Customer Value Leadership Award.
Winner of South Australian Premier’s Export Awards 2022 – International Health
Avance Clinical won the 2022 South Australian Premier’s Export Awards – International Health category. The award recognizes excellence in clinical services exports.
Finalist 2022 Informa Pharma Intelligence Awards Japan – Best Contract Research Organization in APAC
This Award recognizes CROs that provide full or specialist services to their clients and which have an office in either in Japan or the Asia region including Australia.
Winner of Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award
Avance Clinical, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC) CRO Best Practices Award for the company from Frost & Sullivan.
Proven industry
experience & expertise
500+
Studies in the past 5 years
450+
Experienced team members
18k+
Participants past 5 years
30
Years of CRO experience